| 3 | 1/1 | 返回列表 |
| 查看: 815 | 回復(fù): 2 | |||
| 本帖產(chǎn)生 1 個(gè) 翻譯EPI ,點(diǎn)擊這里進(jìn)行查看 | |||
三葉草王鐵蟲(chóng) (正式寫(xiě)手)
|
[求助]
英譯漢,謝謝
|
||
|
1.Transfections with has-miR-29a, -29b-1, -29c mimics and negative control (Ambion, Austin, TX, USA) were performed at a concentration of 100 nM with Lipofectamine 2000 (Invitrogen,Carlsbad, CA, USA). The expressions of DNMT1, DNMT3A and DNMT3B were knocked down stably in A549 and H1299 cell lines。using a lentiviral shRNA system from Santa Cruz Biotechnology (Dallas, Texas, USA) with puromycin selection. Transient knock down of WIF-1 was achieved by using WIF-1 shRNA Plasmid (Santa Cruz) according to the manufacturer’s instructions. For the demethylation assay, 5-Aza-deoxycytidine (5-Aza, Sigma–Aldrich, St. Louis, MO, USA) was added at a concentration of 10lM for 72 h 2 . Methylation-Specific PCR (MSP) Genomic DNA was extracted with the DNA Maxi Kit (Qiagen, Valencia, CA), and modified with sodium bisulfite using the MethylCode Bisulfite Conversion Kit (Invitrogen) according to the manufacturer’s protocol. The methylation-specific or unmethylation-specific primer (MSP or USP) for WIF-1 was designed according to a previous report[7](Table 1). MiR-29s are transcribed into two primary transcripts from two chromosomes (miR-29b1and miR-29a at chromosome 7q32; miR-29b2 and miR-29c at chromosome 1q32). The MSP and USP were designed using the MethPrimer program (https://www.urogene.org/cgi-bin/methprimer/methprimer). Primers for miR-29b1 and miR-29a correspond to the promoter region sequences 1112 to1085 and993 to 971, respectively (Table 1). Primers for miR-29b2 and miR-29c correspond to the promoter region sequences 1339 to1314 and1178 to1153, respectively (Table 1). 3. Cell proliferation assays Cancer cells were transfected with microRNA mimics and/or WIF-1 shRNA. Seventy-two hours after transfection, cells wereseeded into 96-well plates (510 3 cells per well), and incubated at 37C. The number of viable cells was measured at daily intervals. A volume of 10lL of 5 mg/mL 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) was added to each well and incubated for 4 h. The precipitate formed was dissolved by addition of 100lL of dimethyl sulfoxide and absorbance was measured at 562 nm using an ELISA reader (Bio-Rad Laboratories, Hercules, CA, USA). Each experiment was performed in triplicate and repeated three times 4. Apoptosis assay Cells were seeded in 6-well plates at a density of 110 6 cells per well and transfected with microRNA mimics and/or WIF-1 shRNA. Seventy-two hours after transfection, the cells were resuspended and stained with FITC-conjugated anti-annexin V antibody and propidium iodide (PI) using the Annexin V-FITC Apoptosis Detection Kit (Sigma–Aldrich). Stained cells were then quantified by FACSCalibur flow cytometry (Becton Dickinson, USA). 5. Statistical analysis Differences between two groups were assessed by the Student’s t-test or Mann–Whitney’s U-test. Correlations were assessed by Pearson’s correlation test. Variance analysis between multiple groups was performed by one-way ANOVA. The data were presented as mean ± standard deviation (SD) andp< 0.05 was considered statistically significant |

至尊木蟲(chóng) (知名作家)
Translator and Proofreader
|
1. 采用Lipofectamine 2000 (Invitrogen,Carlsbad, CA, USA)轉(zhuǎn)染hsa-miR-29a、 -29b-1、-29c(模擬物)以及陰性對(duì)照 (Ambion, Austin, TX, USA) ,濃度為100 nM。在A549和H1299細(xì)胞中利用慢病毒載體shRNA系統(tǒng)(含有嘌呤霉素篩選標(biāo)記)(Santa Cruz Biotechnology,Dallas, Texas, USA)穩(wěn)定轉(zhuǎn)染方法敲減DNMT1、DNMT3A和DNMT3B的表達(dá)。根據(jù)生產(chǎn)商說(shuō)明書(shū)利用WIF-1 shRNA Plasmid (Santa Cruz)瞬時(shí)敲減WIF-1(的表達(dá))。去甲基化實(shí)驗(yàn)時(shí),用10 μM 5-Aza (Sigma–Aldrich, St. Louis, MO, USA) 處理72小時(shí)。 2 . 甲基化特異性PCR (MSP) 用DNA Maxi Kit(Qiagen, Valencia, CA)提取基因組DNA,并用MethylCode™ Bisulfite Conversion Kit (Invitrogen)根據(jù)生產(chǎn)商使用手冊(cè)進(jìn)行亞硫酸氫鈉進(jìn)行修飾。根據(jù)以前的報(bào)告[7]設(shè)計(jì)WIF-1甲基化特異性引物和非甲基化特異引物(MSP或USP)(表1)。MiR-29s從兩個(gè)不同染色體上轉(zhuǎn)錄成兩個(gè)主要轉(zhuǎn)錄產(chǎn)物(miR-29b1和miR-29a在染色體7q32; miR-29b2和miR-29c在染色體1q32)。MSP和USP用MethPrimer程序設(shè)計(jì) (https://www.urogene.org/cgi-bin/methprimer/methprimer)。 The MSP and USP were designed using the MethPrimer program (https://www.urogene.org/cgi-bin/methprimer/methprimer)。miR-29b1引物和miR-29a引物分別對(duì)應(yīng)于啟動(dòng)子區(qū)域順序1112到1085、及993到971 (表1)。miR-29b2引物和miR-29c引物分別對(duì)應(yīng)于啟動(dòng)子順序的1339至1314和1178至1153(表1)。 3. 細(xì)胞增殖實(shí)驗(yàn) 腫瘤細(xì)胞轉(zhuǎn)染microRNA模擬物和/或WIF-1 shRNA。轉(zhuǎn)染后72小時(shí),細(xì)胞種植于96孔板(5000細(xì)胞/孔),并于37度培養(yǎng)。每天計(jì)數(shù)活細(xì)胞數(shù)量。每孔加入10 μl 5 mg/ml的MTT并繼續(xù)培養(yǎng)4小時(shí)。所形成的沉淀溶于100 μl而家亞砜,并用ELISA酶標(biāo)儀 (Bio-Rad Laboratories, Hercules, CA, USA)檢測(cè)562 nm的光吸收度。每一實(shí)驗(yàn)設(shè)三個(gè)平行實(shí)驗(yàn),同樣的實(shí)驗(yàn)重復(fù)三次。 4. 凋亡檢測(cè) 細(xì)胞種植于6孔板中,密度為每孔1百萬(wàn)細(xì)胞,用microRNA模擬物和/或WIF-1 shRNA轉(zhuǎn)染。轉(zhuǎn)染后72小時(shí),再次懸浮細(xì)胞并用FITC交聯(lián)的抗膜聯(lián)蛋白V抗體和碘化丙啶(PI)對(duì)細(xì)胞染色,染色采用膜聯(lián)蛋白V-FITC凋亡檢測(cè)試劑盒 (Sigma–Aldrich)進(jìn)行。用FACSCalibur流式細(xì)胞儀 (Becton Dickinson, USA)對(duì)染色細(xì)胞進(jìn)行定量。 5. 用Student’s t檢驗(yàn)或Mann–Whitney’s U檢驗(yàn)對(duì)兩組間的差異進(jìn)行統(tǒng)計(jì)學(xué)分析。用Pearson’s的相關(guān)檢驗(yàn)進(jìn)行相關(guān)分析。通過(guò)單因素方差分析進(jìn)行多組間方差分析。數(shù)據(jù)用均數(shù)±標(biāo)準(zhǔn)差(SD)表示,視p< 0.05為有顯著統(tǒng)計(jì)學(xué)意義。 |
至尊木蟲(chóng) (知名作家)
Translator and Proofreader
|
剛才忘了刪掉部分原文,以下文為準(zhǔn): 1. 采用Lipofectamine 2000 (Invitrogen,Carlsbad, CA, USA)轉(zhuǎn)染hsa-miR-29a、 -29b-1、-29c(模擬物)以及陰性對(duì)照 (Ambion, Austin, TX, USA) ,濃度為100 nM。在A549和H1299細(xì)胞中利用慢病毒載體shRNA系統(tǒng)(含有嘌呤霉素篩選標(biāo)記)(Santa Cruz Biotechnology,Dallas, Texas, USA)穩(wěn)定轉(zhuǎn)染方法敲減DNMT1、DNMT3A和DNMT3B的表達(dá)。根據(jù)生產(chǎn)商說(shuō)明書(shū)利用WIF-1 shRNA Plasmid (Santa Cruz)瞬時(shí)敲減WIF-1(的表達(dá))。去甲基化實(shí)驗(yàn)時(shí),用10 μM 5-Aza (Sigma–Aldrich, St. Louis, MO, USA) 處理72小時(shí)。 2 . 甲基化特異性PCR (MSP) 用DNA Maxi Kit(Qiagen, Valencia, CA)提取基因組DNA,并用MethylCode™ Bisulfite Conversion Kit (Invitrogen)根據(jù)生產(chǎn)商使用手冊(cè)進(jìn)行亞硫酸氫鈉進(jìn)行修飾。根據(jù)以前的報(bào)告[7]設(shè)計(jì)WIF-1甲基化特異性引物和非甲基化特異引物(MSP或USP)(表1)。MiR-29s從兩個(gè)不同染色體上轉(zhuǎn)錄成兩個(gè)主要轉(zhuǎn)錄產(chǎn)物(miR-29b1和miR-29a在染色體7q32; miR-29b2和miR-29c在染色體1q32)。MSP和USP用MethPrimer程序設(shè)計(jì) (https://www.urogene.org/cgi-bin/methprimer/methprimer)。miR-29b1引物和miR-29a引物分別對(duì)應(yīng)于啟動(dòng)子區(qū)域順序1112到1085、及993到971 (表1)。miR-29b2引物和miR-29c引物分別對(duì)應(yīng)于啟動(dòng)子順序的1339至1314和1178至1153(表1)。 3. 細(xì)胞增殖實(shí)驗(yàn) 腫瘤細(xì)胞轉(zhuǎn)染microRNA模擬物和/或WIF-1 shRNA。轉(zhuǎn)染后72小時(shí),細(xì)胞種植于96孔板(5000細(xì)胞/孔),并于37度培養(yǎng)。每天計(jì)數(shù)活細(xì)胞數(shù)量。每孔加入10 μl 5 mg/ml的MTT并繼續(xù)培養(yǎng)4小時(shí)。所形成的沉淀溶于100 μl而家亞砜,并用ELISA酶標(biāo)儀 (Bio-Rad Laboratories, Hercules, CA, USA)檢測(cè)562 nm的光吸收度。每一實(shí)驗(yàn)設(shè)三個(gè)平行實(shí)驗(yàn),同樣的實(shí)驗(yàn)重復(fù)三次。 4. 凋亡檢測(cè) 細(xì)胞種植于6孔板中,密度為每孔1百萬(wàn)細(xì)胞,用microRNA模擬物和/或WIF-1 shRNA轉(zhuǎn)染。轉(zhuǎn)染后72小時(shí),再次懸浮細(xì)胞并用FITC交聯(lián)的抗膜聯(lián)蛋白V抗體和碘化丙啶(PI)對(duì)細(xì)胞染色,染色采用膜聯(lián)蛋白V-FITC凋亡檢測(cè)試劑盒 (Sigma–Aldrich)進(jìn)行。用FACSCalibur流式細(xì)胞儀 (Becton Dickinson, USA)對(duì)染色細(xì)胞進(jìn)行定量。 5. 用Student’s t檢驗(yàn)或Mann–Whitney’s U檢驗(yàn)對(duì)兩組間的差異進(jìn)行統(tǒng)計(jì)學(xué)分析。用Pearson’s的相關(guān)檢驗(yàn)進(jìn)行相關(guān)分析。通過(guò)單因素方差分析進(jìn)行多組間方差分析。數(shù)據(jù)用均數(shù)±標(biāo)準(zhǔn)差(SD)表示,視p< 0.05為有顯著統(tǒng)計(jì)學(xué)意義。 |
| 3 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|